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The level of body iron storage and the erythropoietic need for iron are indicated by the serum levels of ferritin
and soluble transferrin receptor (sTfR), respectively. A meta-analysis of five genome-wide association
studies on sTfR and ferritin revealed novel association to the PCSK7 and TMPRSS6 loci for sTfR and the
HFE locus for both parameters. The PCSK7 association was the most significant (rs236918, P 5 1.1 3
10E227) suggesting that proprotein convertase 7, the gene product of PCSK7, may be involved in sTfR gen-
eration and/or iron homeostasis. Conditioning the sTfR analyses on transferrin saturation abolished the HFE
signal and substantially diminished the TMPRSS6 signal while the PCSK7 association was unaffected,
suggesting that the former may be mediated by transferrin saturation whereas the PCSK7-associated
effect on sTfR generation appears to be more direct.
INTRODUCTION
Iron is indispensable for oxygen transport and oxidative
metabolism. The homeostatic distribution of iron to functional
sites (predominantly to haemoglobin in erythrocytes) and
storage (predominantly to ferritin in the liver) is controlled
by a network of local and systemic regulators. The systemic
regulation relies on the hormone hepcidin and the iron
∗To whom correspondence should be addressed at: Institut fu¨r Humangenetik, Klinikum rechts der Isar, TU Mu¨nchen, Trogerstr. 32, 81675 Mu¨nchen,
Germany. Tel: +49 8941406386; Fax: +49 8941406382; Email: oexle@humangenetik.med.tum.de
†These authors contributed equally to the paper.
# The Author 2010. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Molecular Genetics, 2011, Vol. 20, No. 5 1042–1047
doi:10.1093/hmg/ddq538
Advance Access published on December 10, 2010
exporter ferroportin, the local regulation implies iron-
regulatory proteins that bind iron-responsive elements in mes-
senger RNAs (1). For transport in serum, most iron is loaded
to transferrin that attaches to transferrin receptors (TfR) on
target cells. In case of iron deficiency, the fraction of iron-
loaded transferrin, i.e. the transferrin saturation, is low. The
level of iron storage is also indicated by the serum concen-
tration of ferritin leaking into the blood. The erythropoietic
need for iron is revealed by the soluble transferrin receptor
(sTfR) in serum. sTfR reflects the TfR expression on erythroid
precursors (2). Moreover, sTfR generation by TfR cleavage
appears to be inhibited by iron-loaded transferrin (3). As
serum ferritin may rise disproportionately to iron storage
status during inflammation or neoplasia (ferritin being an
acute-phase reactant), sTfR is considered to be a more reliable
index of iron deficiency in anaemia of inflammation (or of
chronic disease) (2).
We measured ferritin and sTfR in five independent popu-
lation cohorts and subjected the log-transformations of these
parameters to a meta-analysis of the individual cohort
genome-wide association study (GWAS) data. While GWAS
on ferritin, on other common iron parameters, and on erythro-
cytes measures have been presented before (4–8), GWAS
results on sTfR have not yet been published. We identified a
strong signal in a gene locus (PCSK7) that is entirely new to
the field of iron homeostasis alongside genes (HFE and
TMPRSS6) that are already known to influence iron par-
ameters.
RESULTS
Meta-analysis of GWAS on log10(ferritin) and log10(sTfR)
revealed three gene loci with genome-wide significance
(Fig. 1; see Supplementary Material, Tables S4 and S5 for
P-values and effect sizes). The strongest and most novel
association was found on chromosome 11q in the analysis of
log10(sTfR). This association signal comprised a 0.4 Mb
region delimited at the distal end by a recombination hot
spot (Fig. 1). The most significantly associated SNP
(rs236918 at 116.6 Mb, P ¼ 10227) was identified within
intron 9 of PCSK7. At the other end of the region, close to
the cluster of apolipoprotein A (APOA) genes, SNPs such as
rs10047462 at 116.2 Mb demonstrated almost equally signifi-
cant association. We tested for possible correlation between
iron (ferritin, sTfR) and lipid (triglycerides, total cholesterol,
HDL, LDL) parameters to see whether such a correlation
drives the association signal since the APOA gene locus is
known to be associated with lipid parameters (9,10).
However, in keeping with previous findings (11), Pearson
coefficients revealed no correlation in our cohorts (absolute
value of correlation ≤0.13; Supplementary Material,
Table S6). Association analysis conditioned on top hit
rs236918 did not show any independent signals at the
APOA cluster with P-values below 1024 but conserved inde-
pendent signals within PCSK7 at a level of almost genome-
wide significance (P ¼ 1.4 × 1026, Fig. 2).
Two further loci were found to have genome-wide signifi-
cance in association with log10(sTfR). One was a pointed
signal on chromosome 22q (Fig. 1) with the most significant
SNP, rs855791, being a common missense mutation
(A736V) in the protease domain of the matriptase-2 gene
TMPRSS6. The other was identical to the most common mis-
sense mutation in the HFE (C282Y) gene (rs1800562) causing
autosomal recessive haemochromatosis type 1 in the homozy-
gous state. The rs1800562 (C282Y) variant of HFE was
associated with both log10(sTfR) and log10(ferritin).
As the transferrin saturation appears to influence sTfR (3), a
meta-analysis of association tests conditioned on transferrin
saturation, i.e. log10(transferrin saturation), was performed
for the top hit in each of the three sTfR associated loci in
order to evaluate whether theses hits were secondary to an
association with transferrin saturation (see Supplementary
Material, Table S7; transferrin saturation was available from
all cohorts except for InChianti.) The HFE hit (rs1800562)
was abolished in the conditional analysis. Similarly, effect
size and significance of the TMPRSS6 hit (rs855791)
substantially declined (from 0.02 and 3 × 10215, respectively,
in the unconditioned analysis without InCHIANTI to 0.01 and
6 × 1026, respectively, in the analysis conditioned on transfer-
rin saturation). The effect of the top hit (rs236918) at the
PCSK7 locus, however, was not affected by the conditioning
and its P-value was even diminished (compared with the
unconditioned analysis without InCHIANTI). In keeping
with these findings, rs236918 was not associated with transfer-
rin saturation (P ¼ 0.3), whereas the top SNPs at the HFE and
TMPRSS6 loci showed associations of genome-wide signifi-
cance (2.4 × 10225 and 1.6 × 10216, respectively).
DISCUSSION
Our GWAS meta-analysis identified both novel and previously
known genetic associations to iron-related parameters. The
association signals detected on rs1800562, the most common
missense mutation in the HFE (C282Y) gene, with both
log10(ferritin) and log10(sTfR) levels indicated our ability to
detect true associations, thus confirming the sensitivity of
our study. C282Y causes autosomal recessive haemochroma-
tosis type 1 (MIM +235200) and is known to influence
common parameters of iron metabolism (including ferritin)
in both homozygous and heterozygous states (12). The associ-
ation of pathogenic HFE mutations with sTfR has been exam-
ined before in a relatively small Catalan population sample
(13) revealing association with another HFE mutation,
rs1799945 (H63D), but not with rs1800562. The minor
allele frequency (MAF) of rs1800562 is low (,5%), possibly
explaining the variability of the association results that was
also evident among the different cohorts in the present study
(Supplementary Material, Tables S4 and S5). While the
mode of action of HFE mutations on sTfR levels remains to
be determined, it may reflect an indirect consequence of the
change in iron homeostasis, i.e. a change in transferrin satur-
ation (3). Indeed, the association of sTfR with rs1800562 van-
ished when the analysis was conditioned on transferrin
saturation (Supplementary Material, Table S7).
Association analysis of log10(sTfR) revealed two other loci
with P-values of genome-wide significance. One was located
at the TMPRSS6 gene locus on chromosome 22q (Fig. 1)
and had the lowest P-value on a common missense mutation
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(A736V, rs855791) within the protease domain of TMPRSS6.
This and other TMPRSS6 SNPs have been found recently to be
associated with other parameters of iron status (i.e. iron and
transferrin saturation) and with erythrocyte phenotypes (4–
8). Homozygous loss-of-function mutations of TMPRSS6
cause iron-refractory iron deficiency anaemia (MIM
#206200) (14). Matriptase-2, the gene product of TMPRSS6,
is assumed to function in iron homeostasis by cleaving haemo-
juvelin at the cell membrane, thus downregulating the bone
morphogenetic protein (BMP)–Smad negative feedback
signal cascade that leads from iron-loaded transferrin in
plasma to hepcidin expression in the liver (15–18). The
association of TMPRSS6 with sTfR may be an indirect result
of this matriptase-2 function, e.g. via a change in iron-loaded
transferrin (i.e. transferrin saturation) that inhibits sTfR gener-
ation (3). Indeed, the associations of the TMPRSS6 missense
mutation A736V (rs855791) with transferrin saturation and
sTfR had opposite directions, and the conditioning on transfer-
rin saturation greatly reduced the sTfR-rs855791 association
(Supplementary Material, Table S7).
Mice heterozygous for TMPRSS6 loss-of-function
mutations are more susceptible to iron deficiency and have
decreased hepatic iron stores (18). However, neither our data
(Pmin ¼ 0.0067, rs5756505, not shown) nor previous reports
(4,8) revealed an association of genome-wide significance
between serum ferritin (which is a marker of body iron
stores) and TMPRSS6 SNPs. The effect of TMPRSS6 variation
on serum ferritin thus appears to be relatively small.
The strongest association to log10(sTfR) comprised a
0.4 Mb region on chromosome 11q (Fig. 1). The most signifi-
cantly associated SNP (rs236918 at 116.6 Mb, P ¼ 10227) was
identified within intron 9 of the PCSK7 gene. Although
association does not necessarily mean causation, PCSK7 is a
physiologically plausible candidate for affecting sTfR levels.
The gene product (proprotein convertase subtilisin/kexin
type 7, PC7/8) is a convertase similar to furin (PCSK3) that
belongs to a family of proteases acting on various physiologi-
cal pathways and having functional overlap in many but not all
circumstances (19). Two possible mechanisms of PCSK7
acting on sTfR can be considered.
First, furin and/or furin-like convertases function in iron
homeostasis by generating soluble haemojuvelin (sHJV)
from cellular haemojuvelin (20,21). Haemojuvelin has a
crucial role in regulation of hepcidin. Membrane-bound hae-
mojuvelin is a coreceptor for BMPs, while sHJV acts as a
decoy receptor (22). Molecular mechanisms of hepcidin down-
regulation by sHJV and by TMPRSS6 (see above) thus seem
to converge on the BMP pathway that transmits signals from
iron-loaded transferrin to hepcidin expression (18). Therefore,
one may speculate that PCSK7, similar to furin, modulates
hepcidin expression via the BMP pathway by influencing
sHJV levels. An effect by BMP activation is also conceivable
(23), but the RTTR amino acid sequence in BMP6, the key
player (16,17) among the BMPs, is only sufficient for furin
but not for PCSK7 cleavage (24). Prohepcidin processing is
another possible mechanism by which proprotein convertases
such as PCSK7 could influence sTfR levels indirectly via
the hepcidin regulation of iron homeostasis (25). Since the
other eight proprotein convertases also might have such
effects on sTfR generation, we tested them for association
with log10(sTfR). However, we did not find a P-value ,
0.001 for any of their intragenic SNPs (data not shown).
PCSK7 is expressed in various tissues including liver (25). It
has a non-redundant function in MHC I-mediated antigen
presentation (19) and, again, an indirect influence via hepcidin
expression [responding to immune reactions (1)] cannot be
excluded.
Alternatively, however, PCSK7 may be involved more
directly in sTfR release from membrane-bound TfR. Indeed,
sTfR is shed from the cell surface by proteolytic cleavage, pri-
marily mediated by a metalloprotease, which is likely acti-
vated by a furin-like convertase, as the activation is sensitive
to inhibitors of these convertases (26). In keeping with this
hypothesis, the top hit (rs236918) at the PCSK7 locus was
not associated with transferrin saturation, and its strong associ-
ation with sTfR was not affected when the analysis was
Figure 1. Loci with genome-wide significance for association with soluble transferrin receptor, log10(sTfR). The top hit of each locus is indicated by a green
diamond. The level of linkage disequilibrium of the top hit with other SNPs in its vicinity is indicated by colouring of the circles that symbolize these SNP: red,
r2. 0.8; orange, 0.8. r2 . 0.5; grey, 0.5. r2 . 0.2; white, 0.2. r2. Genes are represented by green arrows, the recombination rate is displayed as a light
blue graph.
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conditioned on transferrin saturation (Supplementary Material,
Table S7).
PCSK7 knockout mice have been generated and reportedly
do not have an overt pathology (27). However, as emphasized
by Lin et al. (20), iron-related phenotypes may have been
overlooked in these knockout models. They may thus need
further study in light of our association data.
In summary, we identified three gene loci that associate
with sTfR levels in serum. Two of these genes, HFE and
TMPRSS6, associate with other iron parameters, indicating
that physiologically related traits may converge in genomic
association studies. The third, novel association signal
reveals variants at the PCSK7 locus to play a major role in
sTfR generation.
MATERIALS AND METHODS
Ferritin and sTfR were measured in five independent popu-
lation cohorts (KORA F3 and KORA F4, two surveys of the
Cooperative Health Research in the Southern German region
of Augsburg; MICROS, a study on microisolates in South
Tyrol, Italy; InCHIANTI, a study on the population in the
Chianti area of Tuscany, Italy; and CROATIA-VIS, a study
on an island population in Croatia) and subjected to a
meta-analysis of the individual GWAS. A total of 6616 and
6592 individuals were included in the meta-analysis on sTfR
and ferritin, respectively. Furthermore, transferrin saturation
was available in all cohorts except InCHIANTI. Serum par-
ameters were measured by standard laboratory methods, i.e.
by electrochemiluminescence immunoassay (Roche) for ferri-
tin, Tina-quantw immunoturbidometry (Roche) for sTfR, col-
orimetry (Roche) for iron and immunonephelometry
(Siemens) for transferrin in case of KORA F3, KORA F4
and CROATIA-VIS, by microparticle enzyme immunoassay
(Abbott) for ferritin, particle-enhanced immunonephelometry
(Siemens) for sTfR, photometry (ADVIA, Siemens) for iron
and PEG-enhanced immunoturbidometry (Siemens) for trans-
ferrin in case of MICROS, and by chemiluminescent immu-
noassays (Abbott) for ferritin as well as sTfR, and
colorimetry (Roche) for iron in case of InCHIANTI (see Sup-
plementary Material, Table S2). Genotyping was performed
on different platforms, i.e. on Affymetrix platforms in case
of KORA F3 and KORA F4, and on Illumina platforms in
case of MICROS, InCHIANTI and CROATIA-VIS. All
studies used MACH for imputation (28).
The genetic effects were assumed to be additive. The
GWAS on the log10-transformation of ferritin (ng/ml) and
sTfR (mg/l) with age and sex as covariates were calculated
in each cohort separately. Different software was applied
according to the special properties of each cohort data
(see Supplementary Material, Table S3 for details).
In the subsequent meta-analysis, only SNPs with a call rate
≥0.95, a MAF ≥0.01 and an imputation quality r2 hat ≥0.3
were included. Overall significance values and effect sizes
were derived by inverse variance-weighted meta-analysis
using a fixed-effect model in METAL (www.sph.umich.edu/
csg/abecasis/metal). The result of each cohort was corrected
for residual inflation with the genomic control method with cor-
rection for familiarity where necessary. Overall inflation factor
after meta-analysis was small (≤1.01). The threshold for
genome-wide significance was set to the level of 5 × 1028 (29).
In the analysis conditioned on the top hit at the PCSK7
locus, this SNPs’ genotype was treated as covariate in each
study.
Three selected top hits were analysed in each cohort for
association with transferrin saturation using log10-
transformation, age and sex as covariates, and assuming addi-
tive SNP effects. Furthermore, the association analysis of
these top hits and sTfR (log10-transformation) with condition-
ing on transferrin saturation was performed in each cohort (age
and sex as covariates, additive SNP effect). Results were
meta-analysed using METAL. Details on study populations,
phenotypes, genotyping, quality controls and statistical analy-
sis are given in online Supplementary Methods, S-Methods
and Supplementary Material, Tables S1, S2 and S3.
This meta-analysis was conducted according to the prin-
ciples expressed in the Declaration of Helsinki. All contribut-
ing studies were approved by the local ethics committees. All
subjects provided written informed consent for the collection
of samples and subsequent analysis.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
Figure 2. Meta-analysis of association studies of log10(sTfR) conditioned on
rs236918 (blue diamond), the top hit at the PCSK7 locus in unconditioned
analysis. No signal with genome-wide significance is left in conditional analy-
sis, indicating that there is no second hit in this region. However, SNPs within
the PCSK7 gene (e.g. rs17120532, green diamond) that are not in LD with
rs236918 (r2, 0.2) keep a signal of almost genome-wide significance
(1026), suggesting that there are several alleles of PCSK7 influencing sTfR.
The level of linkage disequilibrium of rs236918 with other SNPs in its vicinity
is indicated as in Figure 1 by colouring of the circles that symbolize these
SNP: red, r2. 0.8; orange, 0.8. r2 . 0.5; grey, 0.5. r2. 0.2; white,
0.2. r2. Genes are represented by green arrows, the recombination rate is dis-
played as a light blue graph.
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